Dailypharm Live Search Close

There is no problem with AZ vaccine safety

By Kim, Jung-Ju | translator Choi HeeYoung

21.04.28 11:33:16

°¡³ª´Ù¶ó 0
Domestic vaccines are aimed at development in the first half of next year

Domestic vaccine R&D is supported until the end, such as review of comparative clinical trials


The government announced that it is concerned about the avoidance of the AstraZenega (AZ) COVID-19 vaccine due to the thrombosis side effect issue. It is said that there are no safety issues with side effects and solutions that appear around the world.

Son Young-rae, Team Leader of Countermeasure Headquarters COVID-19 Social Strategy, answered this way through Q&A for regular briefings in the morning of today (28th).

He said, "Recently, the amount of COVID-19 vaccine secured by purchasing additional Pfizer vaccines has increased to a total of 99 million this year. As the supply of vaccines from other companies is increasing, we are concerned about the phenomenon of avoiding AZ vaccinatio

Kim, Jung-Ju(jj0831@dailypharm.com)
If you want to see the full article, please JOIN US (click)